These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Rifaximin is a gut-specific human pregnane X receptor activator. Ma X; Shah YM; Guo GL; Wang T; Krausz KW; Idle JR; Gonzalez FJ J Pharmacol Exp Ther; 2007 Jul; 322(1):391-8. PubMed ID: 17442842 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation. Cheng J; Shah YM; Ma X; Pang X; Tanaka T; Kodama T; Krausz KW; Gonzalez FJ J Pharmacol Exp Ther; 2010 Oct; 335(1):32-41. PubMed ID: 20627999 [TBL] [Abstract][Full Text] [Related]
4. Activation of intestinal human pregnane X receptor protects against azoxymethane/dextran sulfate sodium-induced colon cancer. Cheng J; Fang ZZ; Nagaoka K; Okamoto M; Qu A; Tanaka N; Kimura S; Gonzalez FJ J Pharmacol Exp Ther; 2014 Dec; 351(3):559-67. PubMed ID: 25277138 [TBL] [Abstract][Full Text] [Related]
5. Rifaximin stimulates nitrogen detoxification by PXR-independent mechanisms in human small intestinal organoids. de Wit K; Beuers U; Mukha A; Stigter ECA; Gulersonmez MC; Ramos Pittol JM; Middendorp S; Takkenberg RB; van Mil SWC Liver Int; 2023 Mar; 43(3):649-659. PubMed ID: 36463417 [TBL] [Abstract][Full Text] [Related]
6. Pregnane-X-receptor mediates the anti-inflammatory activities of rifaximin on detoxification pathways in intestinal epithelial cells. Mencarelli A; Migliorati M; Barbanti M; Cipriani S; Palladino G; Distrutti E; Renga B; Fiorucci S Biochem Pharmacol; 2010 Dec; 80(11):1700-7. PubMed ID: 20816942 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of NF-κB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells. Mencarelli A; Renga B; Palladino G; Claudio D; Ricci P; Distrutti E; Barbanti M; Baldelli F; Fiorucci S Eur J Pharmacol; 2011 Oct; 668(1-2):317-24. PubMed ID: 21806984 [TBL] [Abstract][Full Text] [Related]
8. Pregnane X receptor promotes ethanol-induced hepatosteatosis in mice. Choi S; Neequaye P; French SW; Gonzalez FJ; Gyamfi MA J Biol Chem; 2018 Jan; 293(1):1-17. PubMed ID: 29123032 [TBL] [Abstract][Full Text] [Related]
9. Pregnane X receptor as a target for treatment of inflammatory bowel disorders. Cheng J; Shah YM; Gonzalez FJ Trends Pharmacol Sci; 2012 Jun; 33(6):323-30. PubMed ID: 22609277 [TBL] [Abstract][Full Text] [Related]
10. Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis. Gwag T; Meng Z; Sui Y; Helsley RN; Park SH; Wang S; Greenberg RN; Zhou C J Hepatol; 2019 May; 70(5):930-940. PubMed ID: 30677459 [TBL] [Abstract][Full Text] [Related]
11. Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanisms. Bitter A; Rümmele P; Klein K; Kandel BA; Rieger JK; Nüssler AK; Zanger UM; Trauner M; Schwab M; Burk O Arch Toxicol; 2015 Nov; 89(11):2089-103. PubMed ID: 25182422 [TBL] [Abstract][Full Text] [Related]
12. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Zhou J; Febbraio M; Wada T; Zhai Y; Kuruba R; He J; Lee JH; Khadem S; Ren S; Li S; Silverstein RL; Xie W Gastroenterology; 2008 Feb; 134(2):556-67. PubMed ID: 18242221 [TBL] [Abstract][Full Text] [Related]
13. EFFECT OF PREGNANE XENOBIOTIC RECEPTOR ACTIVATION ON INFLAMMATORY BOWEL DISEASE TREATED WITH RIFAXIMIN. Wan YC; Li T; Han YD; Zhang HY; Lin H; Zhang B J Biol Regul Homeost Agents; 2015; 29(2):401-10. PubMed ID: 26122229 [TBL] [Abstract][Full Text] [Related]
14. Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis. Terc J; Hansen A; Alston L; Hirota SA Eur J Pharm Sci; 2014 May; 55():12-9. PubMed ID: 24486481 [TBL] [Abstract][Full Text] [Related]
15. Role of nuclear pregnane X receptor in Cu-induced lipid metabolism and xenobiotic responses in largemouth bass ( Li H; Gong W; Wang G; Yu E; Tian J; Xia Y; Li Z; Zhang K; Xie J Front Endocrinol (Lausanne); 2022; 13():950985. PubMed ID: 35966089 [TBL] [Abstract][Full Text] [Related]
16. Pregnane X receptor (PXR) deficiency improves high fat diet-induced obesity via induction of fibroblast growth factor 15 (FGF15) expression. Zhao LY; Xu JY; Shi Z; Englert NA; Zhang SY Biochem Pharmacol; 2017 Oct; 142():194-203. PubMed ID: 28756207 [TBL] [Abstract][Full Text] [Related]
17. Metabolomics reveals dysregulated all-trans retinoic acid and polyunsaturated fatty acid metabolism contribute to PXR-induced hepatic steatosis in mice. Yan L; Yan Y; Yang K; Chang Q; Zhang L Toxicol Lett; 2024 Jul; 398():150-160. PubMed ID: 38971454 [TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. Johnson CH; Bonzo JA; Cheng J; Krausz KW; Kang DW; Luecke H; Idle JR; Gonzalez FJ Drug Metab Dispos; 2013 Feb; 41(2):406-13. PubMed ID: 23160821 [TBL] [Abstract][Full Text] [Related]
19. Mice blocking Ser347 phosphorylation of pregnane x receptor develop hepatic fasting-induced steatosis and hypertriglyceridemia. Yokobori K; Gruzdev A; Negishi M Biochem Biophys Res Commun; 2022 Jul; 615():75-80. PubMed ID: 35609418 [TBL] [Abstract][Full Text] [Related]
20. Coordinated roles of pregnane X receptor and constitutive androstane receptor in autoinduction of voriconazole metabolism in mice. Ohbuchi M; Yoshinari K; Kaneko H; Matsumoto S; Inoue A; Kawamura A; Usui T; Yamazoe Y Antimicrob Agents Chemother; 2013 Mar; 57(3):1332-8. PubMed ID: 23274663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]